Abstract
Purpose
To compare the efficacy of α1D-receptor antagonist Naftopidil and α1A/D-receptor antagonist Tamsulosin in management of distal ureteral stones.
Materials and methods
A total of 131 patients with distal ureteral stones were included in the study from December 2008 to September 2010. The patients were randomized to 3 groups: group 1 (43 patients), those receiving 10 mg naftopidil once daily; group 2 (45 patients), those receiving 0.4 mg tamsulosin once daily; and group 3 (43 patients) were given a watchful waiting and served as control group. All patients were followed up for 2 weeks. Ultrasonography and kidney-ureters-bladder (KUB) were performed on day 7 and 14. At the end of the follow-up period, patients who failed to expel the stone were scheduled to undergo ESWL or ureteroscopy.
Results
Stone expulsion was observed in 31 patients in group 1 (72.1%), 37 patients in group 2 (82.2%), and 13 patients in group 3 (30.2%). A statistically significant difference was noted with Chi-square testing between groups 1 and 3, and groups 2 and 3 (P = 0.000 and P = 0.000, respectively). Average time to expulsion was 7.6 ± 2.26 days (range 1–12 days) in group 1, 7.7 ± 1.94 days (range 2–11 days) in group 2, and 9.4 ± 2.48 days (range 6–14 days) in group 3. A statistically significant difference was observed in time to expulsion between groups 1 and 3, and groups 2 and 3 (P = 0.000, P = 0.001, respectively) by ANOVA testing. The side effects encountered in the study groups were generally mild and did not require cessation of therapy in any patient.
Conclusions
Naftopidil could significantly increase spontaneous passage of distal ureteral stones with low side effects. The stone expulsion rate is similar for the tamsulosin.
Similar content being viewed by others
References
Bensalah K, Pearle M, Lotan Y (2008) Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 53:411–419
De Sio M, Autorino R, Di Lorenzo G, Damiano R, Giordano D, Cosentino L (2006) Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol 20:12–15
Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56(3):455–471
Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM (2004) Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172:568–570
Dellabella M, Milanese G, Muzzonigro G (2005) Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174:167–171
Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202–2205
Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753
Sigala S, Dellabella M, Milanese G et al (2004) Alpha-1adrenoceptor subtypes in men juxtavesical ureters: molecular and pharmacological characterization. Eur Urol 3:119
Cervenakov I, Fillo J, Mardiak J et al (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha-1 blocker-tamsulosin. Int Urol Nephrol 34:25–29
Canda AE, Turna B, Cinar GM, Nazli O (2007) Physiology and pharmacology of the human ureter: basis for current and future treatments. Urol Int 78:289–298
Kinnman E, Nygards EB, Hansson P (1997) Peripheral alpha-adrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain 69:79–85
Sigala S, Dellabella M, Milanese G et al (2005) Evidence for the presence of α1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142–148
Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM (1987) Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 137:132–135
Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T (2006) Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int 97:747–751
Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T (1999) Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 79:447–454
Malin JM Jr, Deane RF, Boyarsky S (1970) Characterisation of adrenergic receptors in human ureter. Br J Urol 42:171–174
Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 713:2010–2012
Porpiglia F, Vaccino D, Billia M et al (2006) Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 50:339–344
Wolf JS Jr (2007) Treatment selection and outcomes: ureteral calculi. Urol Clin N Am 34:409–410
Wang CJ, Huang SW, Chang CH (2008) Efficacy of an α1 blocker in expulsive therapy of lower ureteral stones. J Endourol 22:41–42
Segura JW, Preminger G, Assimos M et al (1997) Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. J Urol 158:195
Gettman MT, Segura JW (2005) Management of ureteric stones: issues and controversies. BJU Int 95:85–93
Hubner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 24:172
Ueno A, Kawamura T, Ogawa A, Takayasu H (1977) Relation of spontaneous passage of ureteral calculi to size. Urology 10:544
Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101
Shokeir AA (2001) Renal colic: pathophysiology, diagnosis and treatment. Eur Urol 39:241–249
Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quarantelli C et al (1994) Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double blind, placebo controlled study. J Urol 152:1095
Porpiglia F, Destefanis P, Fiori C, Fontana D (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureteralstones. Urology 56:579
Hermanns T, Sauermann P, Rufibach K, Frauenfelder T, Sulser T, Strebel RT (2009) Is there a role for tamsulosin in the treatment of distal ureteral stones smaller than 7 mm? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 56:407–412
Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P (2009) Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology 73:706–709
Al-Ansari A, Al-Naimi A, Alobaidy A et al (2010) Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology 75:4–7
Conflict of interest
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, S.G., Lu, J.L. & Hui, J.H. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol 29, 767–771 (2011). https://doi.org/10.1007/s00345-011-0739-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-011-0739-3